Baumal Caroline Insider Trading Activity (APLS)

Summary

Updated Jul 16, 2026

Baumal Caroline has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $175K.

Profile

Caroline Baumal is the Chief Medical Officer of Apellis Pharmaceuticals, Inc., a public biopharmaceutical company focused on complement inhibitors. The most recent SEC filing (as of 2026-01-06) identifies her as an insider holding the Chief Medical Officer role, with no reported purchases or sales. In this capacity, she is associated with the medical strategy and clinical development for Apellis' therapeutic programs.

Role	Insider
Notability	42/100

Board memberships

Apellis Pharmaceuticals, Inc.

Awards & honors

Appointed Chief Medical Officer at Apellis Pharmaceuticals
Oversees medical strategy and clinical development for Apellis' pipeline
Contributes to advancement of complement inhibitor programs

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	D — Derivative transaction	29.7K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	D — Derivative transaction	12.7K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	D — Derivative transaction	8.9K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	D — Derivative transaction	26.4K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	A — Grant or award	26.4K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	D — Derivative transaction	41.2K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	A — Grant or award	41.2K	—
2026-05-14	APLS	Apellis Pharmaceuticals, Inc.	J — Other acquisition / disposition	86.5K	—
2026-05-01	APLS	Apellis Pharmaceuticals, Inc.	G — Bona-fide gift	900	$0.00
2026-01-23	APLS	Apellis Pharmaceuticals, Inc.	S — Open-market sale	2.8K	$21.77	$61K
2026-01-21	APLS	Apellis Pharmaceuticals, Inc.	S — Open-market sale	1.9K	$19.79	$37K
2026-01-06	APLS	Apellis Pharmaceuticals, Inc.	S — Open-market sale	3.0K	$25.53	$77K

Frequently Asked Questions

Who is Baumal Caroline?

How many SEC Form 4 filings has Baumal Caroline submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Baumal Caroline been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($175K) across all tracked filings.

Where can I see all of Baumal Caroline's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Baumal Caroline — SEC Form 4 Insider Trading Activity